New Treatment for Triple Negative Metastatic Breast Cancer
Breast cancer is a major killer in women the world over. Despite attempts by health organizations to create awareness, screening methods to detect the cancer early, and the availability of effective and safe medications, there are still a large number of women who present with the cancer at a late stage when it has spread beyond the breast, often with fatal consequences. Triple negative breast cancer is a type of breast cancer that lacks three well categorized molecular components, the progesterone receptors, the estrogen receptors and the HER-2 receptors. Pembrolizumab, an immune-based treatment, may be effective in treating triple negative breast cancer that has spread to distant sites, irrespective of whether the patient had received prior treatments for the cancer.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer